We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

EMD Chemicals Expands Multi-Analyte Portfolio Via Collaboration with MitoSciences

News   Oct 23, 2009

 
EMD Chemicals Expands Multi-Analyte Portfolio Via Collaboration with MitoSciences
 
 
Advertisement
 

RELATED ARTICLES

Hydroxychloroquine and Lopinavir/Ritonavir Treatment Arms for COVID-19 Discontinued

News

The World Health Organization (WHO) has accepted the recommendation from the Solidarity Trial’s International Steering Committee to discontinue hydroxychloroquine and lopinavir/ritonavir study arms.

READ MORE

Human Cell “Membrane-on-Chip'” Helps Hunt for Drugs Against COVID-19

News

Researchers have created a human cell '"membrane on a chip" that allows continuous monitoring of how drugs and infectious agents interact with our cells. The device could soon be used to screen potential drug candidates against SARS-CoV-2.

READ MORE

Asthma Drug Salbutamol Inhibits Tau Filament Formation In Vitro

News

A new study suggests that the common asthma drug called salbutamol may offer potential as a treatment for Alzheimer’s disease. Extensive analytical in vitro experiments show that salbutamol is effective at reducing the accumulation of insoluble fibres of the tau protein – which is found in the brains of people with Alzheimer’s disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE